icon-folder.gif   Conference Reports for NATAP  
 
  62th Annual Meeting of the American Association for the Study of Liver Diseases San Francisco 2011 Nov 6-9 Back grey_arrow_rt.gif
 
 
 
Treatment Week 12/24 Stopping Rules for Boceprevir (BOC) Combination Therapy with Peginterferon+Ribavirin (PR): Exploratory Analyses of SPRINT-2 and RESPOND-2
 
 
  Reported by Jules Levin
AASLD Nov 5-8 2011
 
Ira M. Jacobson MD1, Patrick Marcellin MD2, Stefan Zeuzem MD3, Mark S. Sulkowski MD4, Rafael Esteban MD5, Lisa D. Pedicone PhD6
 
Navdeep Boparai PhD6, Margaret Burroughs MD6, Clifford A. Brass MD PhD6, Janice K. Albrecht PhD6, Jean-Pierre Bronowicki MD, PhD7

AASLD1.gif

AASLD2.gif

AASLD3.gif

AASLD4.gif

AASLD5.gif

AASLD6.gif

AASLD7.gif